FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117861335> ?p ?o ?g. }

• W2117861335 endingPage "1049" @default.
• W2117861335 startingPage "1041" @default.
• W2117861335 abstract "Seven years have elapsed since the Scottish Government launched its Hepatitis C Action Plan - a Plan to improve services to prevent transmission of infection, particularly among people who inject drugs (PWID), identify those infected and ensure those infected receive optimal treatment. The Plan was underpinned by industrial scale funding (around £100 million, in addition to the general NHS funding, will have been invested by 2015), and a web of accountable national and local multi-disciplinary multi-agency networks responsible for the planning, development and delivery of services. Initiatives ranged from the introduction of testing in specialist drug services through finger-prick blood sampling by non-clinical staff, to the setting of government targets to ensure rapid scale-up of antiviral therapy. The Plan was informed by comprehensive national monitoring systems, indicating the extent of the problem not just in terms of numbers infected, diagnosed and treated but also the more penetrative data on the number advancing to end-stage liver disease and death, and also through compelling modelling work demonstrating the potential beneficial impact of scaling-up therapy and the mounting cost of not acting. Achievements include around 50% increase in the proportion of the infected population diagnosed (38% to 55%); a sustained near two-and-a-half fold increase in the annual number of people initiated onto therapy (470 to 1050) with more pronounced increases among PWID (300 to 840) and prisoners (20 to 140); and reversing of an upward trend in the overall number of people living with chronic infection. The Action Plan has demonstrated that a Government-backed, coordinated and invested approach can transform services and rapidly improve the lives of thousands. Cited as an impressive example of a national strategy by the Global Commission on Drug Policy, the Scottish Plan has also provided fundamental insights of international relevance into the management of HCV among PWID." @default.
• W2117861335 created "2016-06-24" @default.
• W2117861335 creator A5004545282 @default.
• W2117861335 creator A5004579061 @default.
• W2117861335 creator A5007119843 @default.
• W2117861335 creator A5012931920 @default.
• W2117861335 creator A5014587516 @default.
• W2117861335 creator A5033189916 @default.
• W2117861335 creator A5038838131 @default.
• W2117861335 creator A5042756680 @default.
• W2117861335 creator A5058071012 @default.
• W2117861335 creator A5062766650 @default.
• W2117861335 creator A5069135365 @default.
• W2117861335 creator A5081388535 @default.
• W2117861335 creator A5083001843 @default.
• W2117861335 creator A5090458618 @default.
• W2117861335 date "2015-11-01" @default.
• W2117861335 modified "2023-09-26" @default.
• W2117861335 title "Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience" @default.
• W2117861335 cites W1487886903 @default.
• W2117861335 cites W1674457507 @default.
• W2117861335 cites W1915531325 @default.
• W2117861335 cites W1935769152 @default.
• W2117861335 cites W1968935658 @default.
• W2117861335 cites W1975600766 @default.
• W2117861335 cites W1980608423 @default.
• W2117861335 cites W1980958334 @default.
• W2117861335 cites W1985434534 @default.
• W2117861335 cites W2002411347 @default.
• W2117861335 cites W2003672974 @default.
• W2117861335 cites W2006747389 @default.
• W2117861335 cites W2014963784 @default.
• W2117861335 cites W2026697567 @default.
• W2117861335 cites W2031965361 @default.
• W2117861335 cites W2045884426 @default.
• W2117861335 cites W2048149685 @default.
• W2117861335 cites W2049120639 @default.
• W2117861335 cites W2058681920 @default.
• W2117861335 cites W2072257689 @default.
• W2117861335 cites W2073310478 @default.
• W2117861335 cites W2094971471 @default.
• W2117861335 cites W2101910709 @default.
• W2117861335 cites W2115399503 @default.
• W2117861335 cites W2122900973 @default.
• W2117861335 cites W2125076558 @default.
• W2117861335 cites W2138053911 @default.
• W2117861335 cites W2143398474 @default.
• W2117861335 cites W2149638499 @default.
• W2117861335 cites W2154259558 @default.
• W2117861335 cites W2155938702 @default.
• W2117861335 cites W2160124272 @default.
• W2117861335 cites W2160638691 @default.
• W2117861335 cites W2162933087 @default.
• W2117861335 doi "https://doi.org/10.1016/j.drugpo.2015.05.019" @default.
• W2117861335 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26123893" @default.
• W2117861335 hasPublicationYear "2015" @default.
• W2117861335 type Work @default.
• W2117861335 sameAs 2117861335 @default.
• W2117861335 citedByCount "26" @default.
• W2117861335 countsByYear W21178613352015 @default.
• W2117861335 countsByYear W21178613352016 @default.
• W2117861335 countsByYear W21178613352017 @default.
• W2117861335 countsByYear W21178613352018 @default.
• W2117861335 countsByYear W21178613352019 @default.
• W2117861335 countsByYear W21178613352020 @default.
• W2117861335 countsByYear W21178613352021 @default.
• W2117861335 countsByYear W21178613352022 @default.
• W2117861335 crossrefType "journal-article" @default.
• W2117861335 hasAuthorship W2117861335A5004545282 @default.
• W2117861335 hasAuthorship W2117861335A5004579061 @default.
• W2117861335 hasAuthorship W2117861335A5007119843 @default.
• W2117861335 hasAuthorship W2117861335A5012931920 @default.
• W2117861335 hasAuthorship W2117861335A5014587516 @default.
• W2117861335 hasAuthorship W2117861335A5033189916 @default.
• W2117861335 hasAuthorship W2117861335A5038838131 @default.
• W2117861335 hasAuthorship W2117861335A5042756680 @default.
• W2117861335 hasAuthorship W2117861335A5058071012 @default.
• W2117861335 hasAuthorship W2117861335A5062766650 @default.
• W2117861335 hasAuthorship W2117861335A5069135365 @default.
• W2117861335 hasAuthorship W2117861335A5081388535 @default.
• W2117861335 hasAuthorship W2117861335A5083001843 @default.
• W2117861335 hasAuthorship W2117861335A5090458618 @default.
• W2117861335 hasBestOaLocation W21178613351 @default.
• W2117861335 hasConcept C108170787 @default.
• W2117861335 hasConcept C111472728 @default.
• W2117861335 hasConcept C138885662 @default.
• W2117861335 hasConcept C144133560 @default.
• W2117861335 hasConcept C159110408 @default.
• W2117861335 hasConcept C18903297 @default.
• W2117861335 hasConcept C2778137410 @default.
• W2117861335 hasConcept C2780210234 @default.
• W2117861335 hasConcept C2908647359 @default.
• W2117861335 hasConcept C41895202 @default.
• W2117861335 hasConcept C512399662 @default.
• W2117861335 hasConcept C71924100 @default.
• W2117861335 hasConcept C86803240 @default.
• W2117861335 hasConcept C99454951 @default.
• W2117861335 hasConceptScore W2117861335C108170787 @default.

• next